Ribavirin Dose Optimization for the Treatment of Hepatitis C
Clinical trial NCT01289496 · COMPLETED
Trial details
- NCT number
- NCT01289496
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-08-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.